These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10843452)

  • 1. Telomerase activity in urine after transurethral resection of superficial bladder cancer and early recurrence.
    Wu XX; Kakehi Y; Takahashi T; Habuchi T; Ogawa O
    Int J Urol; 2000 Jun; 7(6):210-7. PubMed ID: 10843452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subsequential telomerase activity in exfoliated urinary cells detects recurrent disease in bladder cancer after transurethral resection.
    Kitsukawa SI; Ohyashiki K; Yahata N; Ebihara Y; Aizawa T; Ito T; Miki M
    Int J Oncol; 1999 Sep; 15(3):505-10. PubMed ID: 10427132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-invasive prediction of recurrence in bladder cancer by detecting somatic TERT promoter mutations in urine.
    Descotes F; Kara N; Decaussin-Petrucci M; Piaton E; Geiguer F; Rodriguez-Lafrasse C; Terrier JE; Lopez J; Ruffion A
    Br J Cancer; 2017 Aug; 117(4):583-587. PubMed ID: 28683471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase activity in urine after transurethral resection is not a predictive marker for recurrence of superficial bladder cancer.
    Wu XX; Kakehi Y; Nishiyama H; Habuchi T; Ogawa O
    Int J Urol; 2003 Feb; 10(2):117-8. PubMed ID: 12588612
    [No Abstract]   [Full Text] [Related]  

  • 5. FGFR3, TERT and OTX1 as a Urinary Biomarker Combination for Surveillance of Patients with Bladder Cancer in a Large Prospective Multicenter Study.
    Beukers W; van der Keur KA; Kandimalla R; Vergouwe Y; Steyerberg EW; Boormans JL; Jensen JB; Lorente JA; Real FX; Segersten U; Orntoft TF; Malats N; Malmström PU; Dyrskjot L; Zwarthoff EC
    J Urol; 2017 Jun; 197(6):1410-1418. PubMed ID: 28049011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre and postoperative quantitative detection of fragments of cytokeratins 8 and 18 (UBC IRMA) as markers of early recurrence of superficial bladder tumor.
    Gacci M; Serni S; Lapini A; Giubilei G; Dal Canto M; Paladini S; Curotto A; Gallo F; Carmignani G; Carini M
    Arch Ital Urol Androl; 2006 Mar; 78(1):5-10. PubMed ID: 16752880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited significance of routine excretory urography in the follow-up of patients with superficial bladder cancer after transurethral resection.
    Miyake H; Hara I; Yamanaka K; Inoue TA; Fujisawa M
    BJU Int; 2006 Apr; 97(4):720-3. PubMed ID: 16536761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective analysis of transurethral resection, second-look resection, and long-term chemo-metaphylaxis for superficial bladder cancer: indications and efficacy of a differentiated approach.
    Schulze M; Stotz N; Rassweiler J
    J Endourol; 2007 Dec; 21(12):1533-41. PubMed ID: 18186695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Diagnostic and Prognostic Performance of Urinary FGFR3 Mutation Analysis in Bladder Cancer Surveillance: A Prospective Multicenter Study.
    Couffignal C; Desgrandchamps F; Mongiat-Artus P; Ravery V; Ouzaid I; Roupret M; Phe V; Ciofu C; Tubach F; Mentre F; Cussenot O; Grandchamp B
    Urology; 2015 Dec; 86(6):1185-90. PubMed ID: 26364695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion-weighted magnetic resonance imaging in follow-up of superficial urinary bladder carcinoma after transurethral resection: initial experience.
    El-Assmy A; Abou-El-Ghar ME; Refaie HF; Mosbah A; El-Diasty T
    BJU Int; 2012 Dec; 110(11 Pt B):E622-7. PubMed ID: 22757606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activity.
    Kavaler E; Landman J; Chang Y; Droller MJ; Liu BC
    Cancer; 1998 Feb; 82(4):708-14. PubMed ID: 9477104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of telomerase activity and matrix metalloproteinase-9 in voided urine and bladder wash samples as a useful diagnostic tool for bladder cancer.
    Eissa S; Labib RA; Mourad MS; Kamel K; El-Ahmady O
    Eur Urol; 2003 Dec; 44(6):687-94. PubMed ID: 14644121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Telomerase activity as marker of superficial tumor of the bladder].
    Arias Fúnez F; Fernández Fernández E; Escudero Barrilero A; Moyano Jato A; Caso Peláez E
    Arch Esp Urol; 2000 Apr; 53(3):231-6. PubMed ID: 10851728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of urine telomerase in the diagnosis of bladder cancer.
    Sanchini MA; Gunelli R; Nanni O; Bravaccini S; Fabbri C; Sermasi A; Bercovich E; Ravaioli A; Amadori D; Calistri D
    JAMA; 2005 Oct; 294(16):2052-6. PubMed ID: 16249419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Urinary cytology studied during 10 days after transurethral resection of bladder tumour and its relation to tumour recurrence].
    Iguchi A; Yoshinaga H; Masaki Z; Tsugitomi H; Wakayama K
    Nihon Hinyokika Gakkai Zasshi; 1991 Sep; 82(9):1430-5. PubMed ID: 1942702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The significance of urine cytology three consecutive days after transurethral resection as a predictor of superficial bladder cancer recurrence].
    Yumura Y; Takase K; Kato Y; Hamano A; Mikata K; Ogo Y; Noguchi S; Satomi Y
    Hinyokika Kiyo; 2004 Mar; 50(3):171-6. PubMed ID: 15148768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated transurethral resection and intravesical BCG for extensive superficial bladder tumors.
    Ozen H; Ekici S; Uygur MC; Akbal C; Sahin A
    J Endourol; 2001 Oct; 15(8):863-7. PubMed ID: 11724131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of urinary nuclear matrix protein-22 and bladder tumour antigen tests with voided urinary cytology in detecting and following bladder cancer: the prognostic value of false-positive results.
    Poulakis V; Witzsch U; De Vries R; Altmannsberger HM; Manyak MJ; Becht E
    BJU Int; 2001 Nov; 88(7):692-701. PubMed ID: 11890239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical experience with transurethral resection of bladder tumor (TUR-Bt) guided by photodynamic diagnosis (PDD)].
    Inoue K; Kuno T; Fukuhara H; Hamaguchi T; Fukata S; Karashima T; Kamada M; Shuin T; Sakakura N; Kasahara K; Watanabe H; Kozai T; Yasuda M; Kataoka S; Tanimura M; Atsushi K; Furihata M
    Nihon Hinyokika Gakkai Zasshi; 2009 Nov; 100(7):661-70. PubMed ID: 19999130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomerase activity in urine in diagnosis and recurrence surveillance of urothelial carcinoma.
    Li Z; Kong C; Wang P; Liu X; Liu T
    Chin Med J (Engl); 2002 Nov; 115(11):1650-2. PubMed ID: 12609080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.